Sam Brusco, Associate Editor05.05.23
Norlase, an ophthalmic laser manufacturer developer, has received FDA 510(k) clearance and CE mark approval for its ECHO Green Pattern Laser photocoagulator.
ECHO is a portable scanning laser photocoagulator that uses MEMS technology. The laser and scanner are integrated into a single delivery device that attaches to compatible slit lamps. It also has no external fiber, a wireless user interface, µSec Mode for tissue-sparing treatment, and voice control of patterns and parameters.
"The FDA clearance and CE mark approval of ECHO is our most significant milestone to date," Oliver Hvidt, CEO and co-founder of Norlase told the press. "The launch of ECHO as the first and only truly portable pattern scanning laser brings a new paradigm to ophthalmologists that treat retina and glaucoma conditions. Our goal has been to develop a pattern laser that is accessible to all ophthalmologists, while maintaining our high level of innovation and precision. ECHO provides all of this in a smart, highly-intuitive product design enabling surgeons to treat with ease."
"The ECHO laser is easy to use, intuitive and efficient," said Dr. Firas Rahhal, partner, Retina-Vitreous Associates Medical Group. "It provides excellent power and good uptake, even when used at lower power settings. The visualization on the slit lamp delivery is excellent, and in one of the cases I performed, this was true despite the presence of significant cataract. Due to these characteristics, along with others like the easy-to-use screen and controls, the ECHO is currently the best available slit lamp pattern laser that I've used."
ECHO is a portable scanning laser photocoagulator that uses MEMS technology. The laser and scanner are integrated into a single delivery device that attaches to compatible slit lamps. It also has no external fiber, a wireless user interface, µSec Mode for tissue-sparing treatment, and voice control of patterns and parameters.
"The FDA clearance and CE mark approval of ECHO is our most significant milestone to date," Oliver Hvidt, CEO and co-founder of Norlase told the press. "The launch of ECHO as the first and only truly portable pattern scanning laser brings a new paradigm to ophthalmologists that treat retina and glaucoma conditions. Our goal has been to develop a pattern laser that is accessible to all ophthalmologists, while maintaining our high level of innovation and precision. ECHO provides all of this in a smart, highly-intuitive product design enabling surgeons to treat with ease."
"The ECHO laser is easy to use, intuitive and efficient," said Dr. Firas Rahhal, partner, Retina-Vitreous Associates Medical Group. "It provides excellent power and good uptake, even when used at lower power settings. The visualization on the slit lamp delivery is excellent, and in one of the cases I performed, this was true despite the presence of significant cataract. Due to these characteristics, along with others like the easy-to-use screen and controls, the ECHO is currently the best available slit lamp pattern laser that I've used."